Matches in Wikidata for { <http://www.wikidata.org/entity/Q86253880> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q86253880 description "assaig clínic" @default.
- Q86253880 description "clinical trial" @default.
- Q86253880 description "clinical trial" @default.
- Q86253880 description "clinical trial" @default.
- Q86253880 description "clinical trial" @default.
- Q86253880 description "ensaio clínico" @default.
- Q86253880 description "ensayo clínico" @default.
- Q86253880 description "ensayu clínicu" @default.
- Q86253880 description "essai clinique" @default.
- Q86253880 description "klinisch onderzoek" @default.
- Q86253880 description "клінічне випробування" @default.
- Q86253880 name "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 name "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 type Item @default.
- Q86253880 label "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 label "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 prefLabel "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 prefLabel "Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer." @default.
- Q86253880 P1050 Q86253880-5D9B9175-0A5F-4D77-823A-C6DC3B614918 @default.
- Q86253880 P1132 Q86253880-4F7E3517-0E7E-4F81-9619-A27A4EA0C176 @default.
- Q86253880 P1476 Q86253880-92B1A8E1-20D9-4F7C-88A1-D1282210DA12 @default.
- Q86253880 P17 Q86253880-920D8C2A-ACC4-4640-81BD-A5B02EAE46D9 @default.
- Q86253880 P1813 Q86253880-0D8691E1-7C88-4354-82A3-23FD9E68AC7B @default.
- Q86253880 P2899 Q86253880-64AFABA5-5D41-4417-98C3-B9F32D7A9BFD @default.
- Q86253880 P3098 Q86253880-DFE0DB68-6E32-4106-B0E0-163C47F7D54B @default.
- Q86253880 P31 Q86253880-8966C335-3EEC-47F2-AFBD-21065BBB35BA @default.
- Q86253880 P4844 Q86253880-0CAF33BD-89F4-49CA-98E8-ACD75C239164 @default.
- Q86253880 P4844 Q86253880-12B5CF01-C2B9-41AD-9DAD-E3E06F25E9E7 @default.
- Q86253880 P4844 Q86253880-24BDC5F1-5144-4287-9A56-15E41CAD1938 @default.
- Q86253880 P4844 Q86253880-4DF10438-B039-4987-B01D-A57272B0FB09 @default.
- Q86253880 P4844 Q86253880-D1224FCC-55E1-4A96-A707-8C5A0830C0B7 @default.
- Q86253880 P4844 Q86253880-F1B1A470-362E-4FCD-BB8C-D0B143EB5EBC @default.
- Q86253880 P580 Q86253880-64C8F511-3939-498B-AD7E-6D1F2FE4CB9A @default.
- Q86253880 P582 Q86253880-CA3AEF24-D784-4A66-8371-16B4195D45C9 @default.
- Q86253880 P6099 Q86253880-20FE08D7-7D82-401F-8B06-54633BBE3245 @default.
- Q86253880 P6099 Q86253880-273DC9D0-CAD0-4A76-BF92-60A3B56C7F87 @default.
- Q86253880 P767 Q86253880-BF7B3787-F171-481C-8782-C555D5A0E134 @default.
- Q86253880 P8363 Q86253880-B496D1AD-9B4D-4E1F-B85E-307616AAA596 @default.
- Q86253880 P1050 Q356033 @default.
- Q86253880 P1132 "+75" @default.
- Q86253880 P1476 "A Multicenter, Phase I/II Study of Sequential Epigenetic and Immune Targeting in Combination With Nab-Paclitaxel/Gemcitabine in Patients With Advanced Pancreatic Ductal Adenocarcinoma." @default.
- Q86253880 P17 Q183 @default.
- Q86253880 P1813 "SEPION" @default.
- Q86253880 P2899 "+18" @default.
- Q86253880 P3098 "NCT04257448" @default.
- Q86253880 P31 Q30612 @default.
- Q86253880 P4844 Q19904005 @default.
- Q86253880 P4844 Q414143 @default.
- Q86253880 P4844 Q416451 @default.
- Q86253880 P4844 Q423762 @default.
- Q86253880 P4844 Q425681 @default.
- Q86253880 P4844 Q7363205 @default.
- Q86253880 P580 "2020-03-01T00:00:00Z" @default.
- Q86253880 P582 "2024-03-01T00:00:00Z" @default.
- Q86253880 P6099 Q42824440 @default.
- Q86253880 P6099 Q5452194 @default.
- Q86253880 P767 Q731938 @default.
- Q86253880 P8363 Q78089383 @default.